GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.
GEHC - GE HealthCare Technologies Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$78.73
DETAILS
HIGH:
$90.00
LOW:
$65.00
MEDIAN:
$80.00
CONSENSUS:
$78.73
UPSIDE:
11.58%
Stock News
GEHC vs. HAE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.
GE HealthCare's Photonova™ Spectra gains CE Mark, expanding international access
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company's proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables clinical adoption of the technology in CE Mark–observing countries and underscores GE HealthCare's commitment to purposeful, customer-driven innovation in computed tomography (CT). “We are proud to deliver this new.
Why Is GE HealthCare (GEHC) Up 3.6% Since Last Earnings Report?
GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock?
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
GE HealthCare (Nasdaq: GEHC) today announced three additions to its Vivid⢠cardiovascular ultrasound portfolio â Vivid⢠Explorer1, Vivid⢠Advanced1 and
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced three additions to its Vivid™ cardiovascular ultrasound portfolio – Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus.
GE HealthCare management to present at upcoming investor conference
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference:Wells Fargo 21st Annua
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference: Wells Fargo 21st Annual Health Conference – Wednesday, September 9, 2026 at 10:15 am ET/9:15am CT A webcast for the event can be accessed on the GE HealthCare website: https://investor.gehealthcare.com/news-events/events at the date and time listed above. About GE HealthCare Technologies Inc. GE HealthCare is a leading global health.
Bank of Nova Scotia Purchases 19,422 Shares of GE HealthCare Technologies Inc. $GEHC
Bank of Nova Scotia increased its position in GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 40.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 67,181 shares of the company's stock after acquiring an additional 19,422 shares during the period.
GEHC Q2 Orders Surge 11.1% as Record Backlog Builds 2027 Visibility
GEHC's 11.1% order growth and record $23.9B backlog improve revenue visibility, but PCS execution and inflation remain key constraints.
Is GEHC a Buy Now as Growth Improves but Execution Risks Persist?
GEHC's valuation discount and growth in imaging and diagnostics support the case, but PCS weakness, inflation and debt keep execution risks elevated.
Here's Why You Should Add GEHC Stock to Your Portfolio for Now
GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI innovation support its growth outlook despite margin pressures.
GE HealthCare Technologies Inc. $GEHC Stock Position Increased by Barrow Hanley Mewhinney & Strauss LLC
Barrow Hanley Mewhinney and Strauss LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 13.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,455,814 shares of the company's stock after purchasing an additional 1,571,226 shares
GE HealthCare Technologies Inc. $GEHC Shares Sold by Allworth Financial LP
Allworth Financial LP trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 62.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,714 shares of the company's stock after selling 43,525 shares during the period.
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws.
Bet on 4 Top-Ranked Stocks With Rising P/E
Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach.
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.
GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
GE HealthCare said on Tuesday it had appointed William Grogan chief financial officer, effective September 14, succeeding Jay Saccaro after he stepped down last month.
Price Targets
GE HealthCare price target raised to $84 from $80 at Evercore ISI
$84.00
(was $69.06)
Evercore ISI
GE HealthCare price target raised to $79 from $75 at BTIG
$79.00
(was $71.54)
BTIG
GE HealthCare price target lowered to $67 from $69 at UBS
$67.00
(was $64.23)
UBS
GE HealthCare price target lowered to $75 from $80 at BTIG
$75.00
(was $64.70)
Ryan Zimmerman
·
BTIG
GE HealthCare initiated with a Market Perform at BMO Capital
$70.00
(was $64.68)
BMO Capital
GE HealthCare initiated with an Outperform at RBC Capital
$80.00
(was $60.64)
RBC Capital
UBS Upgrades GE HealthCare (GEHC) to Neutral
$69.00
(was $64.26)
Graham Doyle
·
UBS
GE HealthCare price target lowered to $80 from $85 at Evercore ISI
$80.00
(was $59.81)
Evercore ISI
GE HealthCare price target lowered to $85 from $89 at Oppenheimer
$85.00
(was $60.03)
Suraj Kalia
·
Oppenheimer
GE HealthCare price target lowered to $78 from $87 at Barclays
$78.00
(was $59.48)
Matt Miksic
·
Barclays
GE HealthCare downgraded to Neutral from Buy at Goldman Sachs
$65.00
(was $59.48)
David Roman
·
Goldman Sachs
GE HealthCare price target lowered to $80 from $98 at Stifel
$80.00
(was $60.06)
Stifel Nicolaus
GE HealthCare price target lowered to $88 from $96 at Piper Sandler
$88.00
(was $73.20)
Piper Sandler
GE HealthCare price target lowered to $90 from $95 at Mizuho
$90.00
(was $72.69)
Mizuho Securities
GE HealthCare price target raised to $87 from $86 at Barclays
$87.00
(was $82.31)
Barclays
GE HealthCare (GEHC) PT Raised to $98 at Stifel
$98.00
(was $82.63)
Rick Wise
·
Stifel Nicolaus
GE HealthCare price target raised to $85 from $80 at Morgan Stanley
$85.00
(was $82.63)
Morgan Stanley
GE HealthCare (GEHC) PT Raised to $91 at BTIG
$91.00
(was $83.69)
Ryan Zimmerman
·
BTIG
GE HealthCare price target raised to $94 from $91 at Piper Sandler
$94.00
(was $78.78)
Piper Sandler
GE HealthCare downgraded to Sell from Neutral at UBS
$77.00
(was $85.30)
UBS